Heather Behanna - Net Worth and Insider Trading
Heather Behanna Net Worth
The estimated net worth of Heather Behanna is at least $6,097 dollars as of 2024-05-08. Heather Behanna is the Director of Design Therapeutics Inc and owns about 1,300 shares of Design Therapeutics Inc (DSGN) stock worth over $6,097. Details can be seen in Heather Behanna's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Heather Behanna has not made any transactions after 2024-03-25 and currently still holds the listed stock(s).
Transaction Summary of Heather Behanna
Heather Behanna Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Heather Behanna owns 2 companies in total, including Entasis Therapeutics Holdings Inc (ETTX) , and Design Therapeutics Inc (DSGN) .
Click here to see the complete history of Heather Behanna’s form 4 insider trades.
Insider Ownership Summary of Heather Behanna
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ETTX | Entasis Therapeutics Holdings Inc | 2019-06-19 | director |
| DSGN | Design Therapeutics Inc | 2024-03-25 | director |
Heather Behanna Latest Holdings Summary
Heather Behanna currently owns a total of 1 stock. Heather Behanna owns 1,300 shares of Design Therapeutics Inc (DSGN) as of March 25, 2024, with a value of $6,097.
Latest Holdings of Heather Behanna
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DSGN | Design Therapeutics Inc | 2024-03-25 | 1,300 | 4.69 | 6,097 |
Holding Weightings of Heather Behanna
Heather Behanna Form 4 Trading Tracker
According to the SEC Form 4 filings, Heather Behanna has made a total of 1 transactions in Design Therapeutics Inc (DSGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Design Therapeutics Inc is the acquisition of 1,300 shares on March 25, 2024, which cost Heather Behanna around $4,862.
Insider Trading History of Heather Behanna
- 1
Heather Behanna Trading Performance
GuruFocus tracks the stock performance after each of Heather Behanna's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Heather Behanna is %. GuruFocus also compares Heather Behanna's trading performance to market benchmark return within the same time period. The performance of stocks bought by Heather Behanna within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Heather Behanna's insider trading performs compared to the benchmark.
Performance of Heather Behanna
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.53 |  | | | | |
| Relative Return to S&P 500(%) | 3.78 | | | | | |
Heather Behanna Ownership Network
Heather Behanna Owned Company Details
What does Entasis Therapeutics Holdings Inc do?
Who are the key executives at Entasis Therapeutics Holdings Inc?
Heather Behanna is the director of Entasis Therapeutics Holdings Inc. Other key executives at Entasis Therapeutics Holdings Inc include 10 percent owner Theravance Inc , VP & Principal Fin & Acct Off Kristie Ann Wagner , and Chief Medical Officer David Altarac .
Entasis Therapeutics Holdings Inc (ETTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Entasis Therapeutics Holdings Inc (ETTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Entasis Therapeutics Holdings Inc (ETTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Entasis Therapeutics Holdings Inc (ETTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entasis Therapeutics Holdings Inc Insider Transactions
Heather Behanna Mailing Address
Above is the net worth, insider trading, and ownership report for Heather Behanna. You might contact Heather Behanna via mailing address: C/o Entasis Therapeutics Holdings Inc., 35 Gatehouse Drive, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
